908 Devices Inc reports results for the quarter ended June 30 - Earnings Summary
05/08/2025 14:31
908 Devices Inc MASS.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -31 cents. The mean expectation of four analysts for the quarter was for a loss of 18 cents per share. Wall Street expected results to range from -20 cents to -16 cents per share. Revenue fell 7.2% to $13.04 million from a year ago; analysts expected $12.17 million. 908 Devices Inc's reported EPS for the quarter was a loss of 37 cents. The company reported a quarterly loss of $13.31 million. 908 Devices Inc shares had fallen by 8.6% this quarter and gained 196.4% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 16.7% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" Wall Street's median 12-month price target for 908 Devices Inc is $6.50, about 0.3% below its last closing price of $6.52 This summary was machine generated from LSEG data August 5 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Jun. 30 2025 | -0.18 | -0.18 | Met |
| Mar. 31 2025 | -0.32 | -0.28 | Beat |
| Dec. 31 2024 | -0.35 | -0.56 | Missed |
| Sep. 30 2024 | -0.28 | 0.04 | Beat |